Seeking Alpha

Furd Turgeson » Comments » LIFE

  • Looking for the Biotech Breakout  [View article]
    BIIB also has Avonex and Rituxan to go along with Tysabri. Both Avonex and Rituxan are multi-billion dollar blockbusters. Beyond that, the major difference is BIIB has over 4 billion in revenue and is a profitable cash cow.
    Jan 19 09:47 am |Rating: +1 -1 |Link to Comment
More on LIFE by Furd Turgeson
Comments by Ticker
Furd Turgeson's
Comments Stats
26 comments
Rating: -2 (24 - 26 )